west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "肾脏替代治疗" 70 results
  • Diagnosis, treatment, and renal replacement therapy of cardio-renal syndrome

    Heart and kidney interact with each other. Cardio-renal syndrome (CRS) refers to conditions where acute or chronic dysfunction of either the heart or the kidney leads to dysfunction of the other. Conventional classification of CRS outlined five subgroups according to the clinical presentation. This review focused on the epidemiology, new bio- markers, drug management, and renal replacement therapy of type Ⅰ and type Ⅱ CRS, which emphasized the multi-discipline collaboration and individualized evaluation, in order to achieve goal-directed approach to renal replacement therapy.

    Release date:2018-07-27 09:54 Export PDF Favorites Scan
  • i-STAT便携式血气分析仪在连续性肾脏替代治疗中的应用

    目的 讨论i-STAT便携式血气分析仪在连续性肾脏替代治疗(CRRT)中的应用。 方法 2012年2月-5月,对92例行CRRT治疗患者采用i-STAT便携式血气分析仪监测分析治疗中各参数变化并及时予以调整。 结果 92例患者治疗中酸碱及电解质的失衡得到及时调整,无意外情况发生。 结论 i-STAT便携式血气分析仪在CRRT治疗中能较好的监测患者的血气及电解质,确保CRRT的安全完成。

    Release date:2016-09-07 02:34 Export PDF Favorites Scan
  • 连续性肾脏替代治疗护士交接班特点与方法

    【摘要】 目的 总结连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)专业护士交接班的特点及重要性,以规范交接班制度,完善交接班内容。 方法 针对CRRT治疗地点的分散性、治疗时间及患者人数不确定性等因素,建立起符合CRRT专业护士的交接班内容与方法。 结果 交接班方法推行以来,从未发生过因交接班不规范而导致治疗事故和护理差错,有效的保证了CRRT的护理质量及工作连续性。 结论 严谨细致的CRRT专业护士交接班方法是患者治疗安全的可靠保证。

    Release date:2016-09-08 09:24 Export PDF Favorites Scan
  • Innovation and development of continuous renal replacement equipment

    Continuous renal replacement therapy (CRRT) originated from intermittent hemodialysis. Over the past 40 years, its application scope has gradually expanded from the initial treatment of kidney diseases alone to the support of multi-organ functions. As a safe, adequate, and flexible therapeutic modality, CRRT has become one of the main means of treating critically ill patients. Continuous innovation in technology, biomaterials and other technologies provides important driving force for the sustainable development of CRRT. This paper reviews the technological innovation and development of CRRT devices. With continuous technological updates and iteration, CRRT can better adapt to clinical needs. Biofeedback, portability, and intelligence are several directions of the development of CRRT, which can provide more accurate and personalized treatment for critically ill patients in different scenarios.

    Release date:2025-04-27 01:50 Export PDF Favorites Scan
  • 心脏直视手术后早期心肌顿抑的诊断与治疗

    目的探讨心脏瓣膜置换术后早期心肌顿抑的诊断及治疗以及其所引起的低心排血量综合征(LCOS)的诊疗。 方法回顾性分析我院 2011 年 1 月至 2018 年 3 月期间 42 例心脏瓣膜置换术后早期出现心肌顿抑导致 LCOS 患者的临床资料,其中男 19 例、女 23 例,年龄 38~55(47.91±5.51)岁。术前左心室舒张末期内径(LVEDD)3.8~6.5(5.3±0.9)cm,左心室射血分数(EF)45%~60%(51.2%±5.3%);冠状动脉粥样硬化性心脏病筛查均为阴性;其中单纯主动脉瓣置换 12 例,二尖瓣置换合并三尖瓣成形 15 例,二尖瓣和主动脉瓣置换 15 例。 结果42 例患者均在术后早期[10~24(18.83±4.24)h]出现无明确原因的 LCOS,大剂量肾上腺素[0.06~0.10 μg/(kg·min)]和去甲肾上腺素[0.1~0.5 μg/(kg·min)]治疗无效而加用主动脉内球囊反搏(IABP)治疗,其中 25 例患者行肾脏替代治疗(CRRT)。IABP 辅助时间 3~10(5.16±1.95)d,CRRT 治疗时间 22~61(42.17±10.75)h。40 例患者痊愈出院,2 例患者院内死亡,1 例死于脓毒血症,1 例患者死于恶性心律失常。 结论心脏瓣膜置换术后早期出现心肌顿抑引起病情突变恶化,如能早期诊断、早期治疗,将取得好的临床结果。IABP 可以减轻心脏负荷,增加冠状动脉灌注,改善循环,有助于患者渡过心肌顿抑期;CRRT 可以改善 LCOS 患者内环境,减轻肾脏负担。两者是成功救治此类患者的重要手段。

    Release date:2019-03-01 05:23 Export PDF Favorites Scan
  • Cost estimation and influencing factor analysis of continuous renal replacement therapy

    Objective To estimate the cost of continuous renal replacement therapy (CRRT) in public hospitals and analyze the main influencing factors of the cost, in order to provide evidence for the optimal application of CRRT technology. Methods In March 2021, activity-based costing was used to estimate and analyze the cost of CRRT, the data of which were collected from 5 hospitals in Jiangsu, Zhejiang, Henan, Sichuan and Xinjiang, and single factor sensitivity analysis was used to find the main influencing factors of the cost. Results The hourly treatment costs of CRRT in the 5 hospitals ranged from 265.30 to 474.44 yuan, with an average of 376.81 yuan. The costs of manpower and filters accounted for the top two largest proportions, the manpower cost of continuous veno-venous hemofiltration and continuous veno-venous hemodiafiltration accounted for 22.90% and 21.51%, respectively, and the filters cost of the two types of CRRT accounted for 15.07% and 17.73%, respectively. The unit cost and cost composition varied greatly between hospitals. There were four factors affecting the unit cost, namely clinical operation, efficiency, price and patient, among which clinical operation difference was the primary factor leading to cost difference. Conclusions The application cost of CRRT technology varies greatly among hospitals, and there are many factors affecting the cost. Public hospitals face great pressure in cost control. It is necessary to strengthen the internal control operation management of public hospitals, establish CRRT clinical operation standards, and improve the quality of medical services in public hospitals.

    Release date:2023-01-16 09:48 Export PDF Favorites Scan
  • Comparison of potassium supplement with infusion pump and traditional potassium supplement in continuous renal replacement therapy

    Objective To explore the feasibility and effect of infusion pump potassium supplementation in continuous renal replacement therapy (CRRT). Methods Patients who underwent CRRT were randomly divided into infusion pump group and traditional way group between March and May 2018. In infusion pump group, 10% potassium chloride was supplemented with infusion pump. In traditional way group, 10% potassium chloride was supplemented in the traditional way, which meant adding potassium in the replacement solution. The peripheral blood potassium level, the potassium well-controlled rate, the incidence of adverse events, the average frequency of replacement liquid bags change, the average pump stopping time, and the delivery dose and potassium supplement dose between the two groups were compared. Results A total of 60 patients were randomly divided into two groups, with 30 cases in each group. The infusion pump group was treated with an average of 6.90 mL/h potassium supplement dose by infusion pump, and in traditional way group, potassium was added to the replacement solution by an average of 9.29 mL/h; there were significant differences between the two groups (P<0.05). When compared with traditional way group, there was no significant differences (P>0.05) in the peripheral blood potassium level and the potassium well-controlled rate of the patients at 0, 2, 8, 12 and 24 hours after CRRT (P>0.05). As for the adverse events rate, average frequency of replacement liquid bags change, average pump stopping time, and potassium supplement dose, there were significant differences between the two groups (P<0.05). Conclusions The application of infusion pump to supply potassium in CRRT is feasible and safe, and is superior to the traditional potassium supplement method. It could be further applied in clinical practice.

    Release date:2018-07-27 09:54 Export PDF Favorites Scan
  • Strategies for the standardized management of acute kidney injury associated with coronavirus disease 2019

    Most patients with coronavirus disease 2019 (COVID-19) have a good prognosis, but a certain proportion of the elderly and people with underlying diseases are still prone to develop into severe and critical COVID-19. Kidney is one of the common target organs of COVID-19. Acute kidney injury (AKI) is a common complication of severe COVID-19 patients, especially critical COVID-19 patients admitted to intensive care units. AKI associated with COVID-19 is also an independent risk factor for poor prognosis in patients. This article mainly focuses on the epidemiological data, possible pathogenesis, diagnostic criteria, and prevention and treatment based on the 5R principle of AKI associated with COVID-19. It summarizes the existing evidence to explore standardized management strategies for AKI associated with COVID-19.

    Release date:2023-08-24 10:24 Export PDF Favorites Scan
  • 连续性肾脏替代治疗串联体外二氧化碳清除技术治疗呼吸衰竭合并急性呼吸窘迫综合征一例

    Release date:2022-08-24 01:25 Export PDF Favorites Scan
  • Application and nursing progress of sustained low-efficiency dialysis

    With chronic kidney disease becoming a public health problem in the world, dialysis treatment model has also become the focus of attention from all walks of life. Sustained low-efficiency dialysis, which adopts the mode of low blood flow and low dialysis volume, is a kind of hybrid renal replacement therapy combining continuous renal replacement therapy and intermittent hemodialysis. It has unique advantages in the treatment of patients with acute and severe renal injury, as well as the dialysis duration, patient activity range and cost. It is the most widely used hybrid renal replacement therapy too. This review summarizes the clinical application and nursing points of sustained low-efficiency dialysis to provide guidance for clinical practice.

    Release date:2019-08-15 01:18 Export PDF Favorites Scan
7 pages Previous 1 2 3 ... 7 Next

Format

Content